Cite
HARVARD Citation
Corren, J. et al. (2022). Baseline type 2 biomarker levels and response to tezepelumab in severe asthma. Allergy. 77 (6), pp. 1786-1796. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Corren, J. et al. (2022). Baseline type 2 biomarker levels and response to tezepelumab in severe asthma. Allergy. 77 (6), pp. 1786-1796. [Online].